Frontier Capital Management CO LLC Aerie Pharmaceuticals Inc Transaction History

Frontier Capital Management CO LLC

$9.58 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$7.02 - $13.33 $2.8 Million - $5.32 Million	-399,103 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$11.32 - $16.63 $121,984 - $179,204	-10,776 Reduced 2.63%	399,103 $4.55 Million
Q2 2021 Aug 09, 2021	SELL	$15.16 - $18.97 $341,009 - $426,711	-22,494 Reduced 5.2%	409,879 $6.56 Million
Q1 2021 May 13, 2021	SELL	$13.12 - $20.9 $451,223 - $718,792	-34,392 Reduced 7.37%	432,373 $7.73 Million
Q4 2020 Jan 19, 2021	SELL	$9.12 - $14.49 $502,548 - $798,456	-55,104 Reduced 10.56%	466,765 $6.31 Million
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $167,600 - $231,692	16,023 Added 3.17%	521,869 $6.14 Million
Q2 2020 Jul 17, 2020	BUY	$12.0 - $16.13 $1.02 Million - $1.38 Million	85,307 Added 20.29%	505,846 $7.47 Million
Q1 2020 Apr 16, 2020	SELL	$11.84 - $25.52 $1.46 Million - $3.16 Million	-123,676 Reduced 22.73%	420,539 $5.68 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $37,938 - $53,739	-2,141 Reduced 0.39%	544,215 $13.2 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $4.06 Million - $6.17 Million	220,293 Added 67.56%	546,356 $10.5 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $14,224 - $23,671	491 Added 0.15%	326,063 $9.64 Million
Q1 2019 May 07, 2019	BUY	$36.32 - $49.25 $7.69 Million - $10.4 Million	211,699 Added 185.91%	325,572 $15.5 Million
Q4 2018 Jan 25, 2019	SELL	$33.0 - $60.04 $14.5 Million - $26.4 Million	-439,372 Reduced 79.42%	113,873 $4.11 Million
Q3 2018 Oct 30, 2018	BUY	$56.15 - $73.9 $10.5 Million - $13.9 Million	187,810 Added 51.39%	553,245 $34.1 Million
Q2 2018 Aug 03, 2018	BUY	$47.85 - $70.45 $17.5 Million - $25.7 Million	365,435 New	365,435 $24.7 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account